These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Stem cell transplantation in primary immunodeficiency disease patients. Sato T; Kobayashi R; Toita N; Kaneda M; Hatano N; Iguchi A; Kawamura N; Ariga T Pediatr Int; 2007 Dec; 49(6):795-800. PubMed ID: 18045274 [TBL] [Abstract][Full Text] [Related]
4. Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies. Díaz de Heredia C; Ortega JJ; Díaz MA; Olivé T; Badell I; González-Vicent M; Sánchez de Toledo J Bone Marrow Transplant; 2008 Apr; 41(7):627-33. PubMed ID: 18084339 [TBL] [Abstract][Full Text] [Related]
5. Unrelated umbilical cord blood transplantation in children with immune deficiency: results of a multicenter study. Frangoul H; Wang L; Harrell FE; Manes B; Calder C; Domm J Bone Marrow Transplant; 2010 Feb; 45(2):283-8. PubMed ID: 19543326 [TBL] [Abstract][Full Text] [Related]
6. Single centre experience of umbilical cord stem cell transplantation for primary immunodeficiency. Bhattacharya A; Slatter MA; Chapman CE; Barge D; Jackson A; Flood TJ; Abinun M; Cant AJ; Gennery AR Bone Marrow Transplant; 2005 Aug; 36(4):295-9. PubMed ID: 15968287 [TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem cell transplantation for children with primary immunodeficiency diseases: single center experience in Jordan. Amayiri N; Al-Zaben A; Ghatasheh L; Frangoul H; Hussein AA Pediatr Transplant; 2013 Jun; 17(4):394-402. PubMed ID: 23692601 [TBL] [Abstract][Full Text] [Related]
8. Advances in hematopoietic stem cell transplantation for primary immunodeficiency. Gennery AR; Cant AJ Immunol Allergy Clin North Am; 2008 May; 28(2):439-56, x-xi. PubMed ID: 18424341 [TBL] [Abstract][Full Text] [Related]
9. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency. Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864 [TBL] [Abstract][Full Text] [Related]
10. The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells. Ayas M; Al-Seraihi A; El-Solh H; Al-Ahmari A; Khairy A; Aldali A; Markiz S; Siddiqui K; Al-Jefri A Biol Blood Marrow Transplant; 2012 Apr; 18(4):627-32. PubMed ID: 21871862 [TBL] [Abstract][Full Text] [Related]
11. Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine. Ahmed N; Leung KS; Rosenblatt H; Bollard CM; Gottschalk S; Myers GD; Carrum G; Heslop HE; Brenner MK; Krance RA Biol Blood Marrow Transplant; 2008 Nov; 14(11):1298-304. PubMed ID: 18940685 [TBL] [Abstract][Full Text] [Related]
12. Pre-engraftment syndrome after unrelated cord blood transplantation: a predictor of engraftment and acute graft-versus-host disease. Park M; Lee SH; Lee YH; Yoo KH; Sung KW; Koo HH; Kang HJ; Park KD; Shin HY; Ahn HS; Chung NG; Cho B; Kim HK; Koh KN; Im HJ; Seo JJ; Han DK; Baek HJ; Kook H; Hwang TJ; Lee EK; Hah JO; Lim YJ; Jung HJ; Park JE; Jang MJ; Chong SY; Oh D; Biol Blood Marrow Transplant; 2013 Apr; 19(4):640-6. PubMed ID: 23380345 [TBL] [Abstract][Full Text] [Related]
13. Allogeneic Hematopoietic Cell Transplantation in Patients with Primary Immunodeficiencies in Korea: Eleven-Year Experience in a Single Center. Yi ES; Choi YB; Lee NH; Lee JW; Sung KW; Koo HH; Kang ES; Kim YJ; Yoo KH J Clin Immunol; 2018 Oct; 38(7):757-766. PubMed ID: 30151618 [TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection. Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367 [TBL] [Abstract][Full Text] [Related]
15. Outcomes of hematopoietic stem cell transplantation in primary immunodeficiency: a report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry. Mitchell R; Nivison-Smith I; Anazodo A; Tiedemann K; Shaw P; Teague L; Fraser C; Carter T; Tapp H; Alvaro F; O'Brien TA Biol Blood Marrow Transplant; 2013 Mar; 19(3):338-43. PubMed ID: 23228588 [TBL] [Abstract][Full Text] [Related]